Winston Pharmaceuticals, Inc. (WPHM)
Winston Pharmaceuticals, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Vernon Hills, IL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $7,741. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -190.4%. Its beta of -982.38 implies it has historically moved less than the broad market.
Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, and discomfort associated with both osteoarthritis and rheumatoid arthritis. They also tackle pain and inflammation linked to inflammatory bowel disease, alongside other specialized therapeutic areas. The organization, initially established as Winston Laboratories, Inc., adopted its present name, Winston Pharmaceuticals, Inc., in November 2008. Founded in 1998, Winston Pharmaceuticals maintains its principal operations in Vernon Hills, Illinois.
Winston Pharmaceuticals, Inc. is most often compared with the following Healthcare names: